Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Evofem Biosciences, Inc. | neot-ex321_28.htm |
EX-31.1 - EX-31.1 - Evofem Biosciences, Inc. | neot-ex311_26.htm |
EX-10.26 - EX-10.26 - Evofem Biosciences, Inc. | neot-ex1026_1330.htm |
EX-10.27 - EX-10.27 - Evofem Biosciences, Inc. | neot-ex1027_1331.htm |
10-K - 10-K - Evofem Biosciences, Inc. | neot-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-208290) and related prospectus of Neothetics, Inc. pertaining to the registration of common stock, preferred stock, debt securities, warrants and units,
(2) Registration Statement (Form S-8 No. 333-203059) pertaining to the 2014 Equity Incentive Plan and 2014 Employee Stock Purchase Plan of Neothetics, Inc., and
(3) Registration Statement (Form S-8 No. 333-200409) pertaining to the Amended and Restated 2007 Stock Plan, as amended, 2014 Equity Incentive Plan and 2014 Employee Stock Purchase Plan;
of our report dated March 29, 2016, with respect to the financial statements of Neothetics, Inc. included in this Annual Report (Form 10-K) of Neothetics, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP |
|
|
|
San Diego, California |
|
March 29, 2016 |